Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplantation can effectively treat stable eyebrow hair loss in alopecia areata patients.

DCPA is a chronic skin condition affecting the lower limbs, mainly in men, with unclear causes and treatments that often don't work well.

Some people with severe hair loss saw hair regrowth after a specific light and drug treatment.

Phototherapy can help treat hair loss in alopecia areata.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

The study found a specific pattern of uneven melanin distribution on balding scalps that could help understand skin diseases caused by light exposure.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Combination therapies might work better for some vitiligo patients, but results vary.

Some people with the skin color loss condition, vitiligo, also develop the skin inflammation condition, lichen planus, possibly due to local trauma, sun damage, or genetic factors.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Treating generalized granuloma annulare is difficult, with PUVA being the most effective option, but relapses are common.

Surgical repigmentation can permanently restore color to white hair in vitiligo patients.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.

Minoxidil and finasteride are key treatments for hair loss.

Bath PUVA therapy works well for a skin condition without as many cancer risks and is cheaper, and iron deficiency might not cause female hair loss.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Retinoids help treat psoriasis effectively, but they can cause side effects and need more research on safe use with other treatments.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.